American Society of Hematology, Blood Advances, 14(2), p. 1719-1737, 2018
DOI: 10.1182/bloodadvances.2017011502
Full text: Download
Key PointsA risk model using donor and recipient cytokine gene polymorphisms and clinical variables significantly improves GVHD risk stratification. The model is useful in identifying patients with low-risk of developing severe GVHD, but results must be confirmed in prospective studies.